Impact of gastroesophageal reflux symptoms on health resource usage and work absenteeism in Spain;Impacto de los síntomas de reflujo gastroesofágico sobre el uso de servicios sanitarios y el absentismo laboral en España

Revista Espanola de Enfermedades Digestivas

Volumn 98, Issue 7, 2006, Pages 518-526

  Rey, Enrique ^a,c   Moreno Elola Olaso, C ^a   Rodriguez Artalejo F ^b   Diaz Rubio M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Absenteeism; Epidemiology; Gastroesophageal reflux; Pyrosis; Utilization of resourses

Indexed keywords

ACETYLSALICYLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ABSENTEEISM; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; DATA ANALYSIS; ESOPHAGOGRAPHY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL RADIOGRAPHY; HEALTH CARE UTILIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; SPAIN; SYMPTOM; TELEPHONE; VALIDATION STUDY; COST OF ILLNESS; ECONOMICS; HEALTH CARE PLANNING; HEALTH SERVICE; MIDDLE AGED; UTILIZATION REVIEW;

ABSENTEEISM; ADULT; AGED; COST OF ILLNESS; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH RESOURCES; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; SPAIN;

EID: 33750136025     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082006000700005     Document Type: Article

References (25)

1. Díaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR 3rd, Rodríguez-Artalejo F. Symptoms of Gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 2004; 19: 95-105.
2. Locke GR, III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ, III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
3. Rey E, Moreno-Elola-Olaso C, Rodríguez Artalejo F, Díaz-Rubio M. Medical Consultation for gastro-oesophageal symptoms: reasons and associated factors. Digestion 2004; 70: 173-7.
4. Haycox A, Einarson T, Eggleston A. The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999; 231 (Supl.): 38-47.
5. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux. Mayo Clin Proc 1994; 69: 539-47.
6. Moreno-Elola-Olaso C, Rey E, Rodríguez-Artalejo F, Locke GR III, Díaz-Rubio M. Adaptation and validation of a gastroesophageal reflux questionnaire for use on a Spanish population. Rev Esp Enferm Dig 2002; 94: 745-51.
7. Levy P, Lemeshow S. Sampling of Populations. New York: Wiley; 2001.
8. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
9. Schwenkglenks M, Marbet UA, Szucs TD. Epidemiology and costs of gastroesophageal reflux disease in Switzerland: A population based study. Soz Prevent 2004; 49: 51-61.
10. DeVault KR, Castell DO. American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 190-200.
11. Cooper GS, Mourad WA, Koroukian SM. Diagnosis and treatment of gastroesophageal reflux disease in Ohio Medicaid patients: practice patterns and temporal trends. Pharmacoepidemiol Drug Saf 2004; 13: 21-7.
12. Bolin TD, Korman MG, Hansky J, Stanton R. Heartburn: community perceptions. J Clin Gastroenterol Hepatol 2000; 15: 35-9.
13. Oliveira SA, Cristos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge, and prevention strategies. Arch Intern Med 1999; 159: 1592-8.
14. Graham DY, Smith JL, Patterson DJ. Why do apparently healthy people use antacid tablets? Am J Gastroenterol 1983; 78: 257-60.
15. Furu K, Straume B. Use of antacids in a general population: the impact of health-related variables, lifestyles and sociodemographic characteristics. J Clin Epidemiol 1999; 52: 509-16.
16. Hurenkamp GJ, Grundmeyer HG, Bindels PJ, Tytgat GN, Van Der Hulst RW. How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practices. J Fam Pract 2002; 51: 241-5.
17. Meineche-Schmidt V, Juhl HH, Ostergaard JE, Luckow A, Hvnegaard A. Costs and efficacy of three different esomeprazole treatment strategies for long-term management of gastro-oesophageal reflux symptoms in primary care. Aliment Pharmacol Ther 2004; 19: 907-15.
18. Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Alim Pharmacol Ther 2003; 17: 1309-17.
19. Valle C, Broglia F, Pistorio A, Tinelli C, Perego M. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci 1999; 44: 1848-52.
20. Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, et al. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Op 2005; 21: 535-43.
21. Henke CJ, Levin TR, Henning JM, Potter LP. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 2000; 95: 788-92.
22. Galán Labaca I, Rodríguez-Artalejo F, Zorrilla Torras B. Reproducibilidad de un cuestionario telefónico sobre factores de riesgo asociados al comportamiento y prácticas preventivas. Gac Sanit 2004; 18: 118-28.
23. Galán I, Rodríguez-Artalejo F, Zorrilla B. Comparación entre encuestas telefónicas y encuestas "cara a cara" domiciliarias en la estimación de hábitos de salud y prácticas preventivas. Gac Sanit 2004; 18: 440-50.
24. Cleary PD, Jette AM. The validity of self-reported physician utilization measures. Med Care 1984; 22: 796-803.
25. Roberts RO, Bergstralh EJ, Schmidt L, Jacobsen SJ. Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol 1996; 49: 989-95.